Immediate Impact

30 standout
Sub-graph 1 of 11

Citing Papers

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
2024 Standout
Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives
2024 Standout
4 intermediate papers

Works of Weining Volinn being referenced

Rapid Efficacy of the Highly Selective α1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies
2009
Silodosin in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia: A 9-Month, Open-label Extension Study
2009
and 3 more

Author Peers

Author Last Decade Papers Cites
Weining Volinn 356 141 163 160 15 417
Shirin Milani 360 208 143 144 10 442
Gary Hoel 458 140 151 254 18 502
Rex Boake 314 281 225 120 10 484
Christian P. Schmidbauer 316 198 138 178 10 406
Mário Reis 280 141 94 92 13 374
Morten Riehmann 282 203 74 146 18 417
Simon S.M. Hou 210 180 86 88 23 419
Tania Hossack 273 314 97 171 21 512
A. C. N. ROGERS 238 247 51 183 11 462
Stefan Heidler 247 40 83 216 17 385

All Works

Loading papers...

Rankless by CCL
2026